214 related articles for article (PubMed ID: 15791455)
1. Hyperthermic isolated regional perfusion with CDDP for bone and soft-tissue sarcoma of the lower limb: pharmacokinetics, thermal dose, toxicity, and feasibility.
Abe S; Tokizaki T; Miki Y; Tateishi A; Ogawa K; Nakano H; Matsushita T
Cancer Chemother Pharmacol; 2005 Jul; 56(1):55-62. PubMed ID: 15791455
[TBL] [Abstract][Full Text] [Related]
2. [Relations of chemotherapy-induced tumor necrosis to plasma platin concentration and primary tumor temperature in patients with osteosarcoma in the lower extremities treated by hyperthermic isolation limb perfusion with cisplatin].
Fan S; Yang D; Tao H; Ye Z; He R
Zhonghua Wai Ke Za Zhi; 2000 May; 38(5):336-9. PubMed ID: 11832050
[TBL] [Abstract][Full Text] [Related]
3. Toxicity and outcomes associated with surgical cytoreduction and hyperthermic intraperitoneal chemotherapy (HIPEC) for patients with sarcomatosis.
Lim SJ; Cormier JN; Feig BW; Mansfield PF; Benjamin RS; Griffin JR; Chase JL; Pisters PW; Pollock RE; Hunt KK
Ann Surg Oncol; 2007 Aug; 14(8):2309-18. PubMed ID: 17541691
[TBL] [Abstract][Full Text] [Related]
4. Intensive preoperative chemotherapy for osteosarcoma in the lower extremity.
Nakano H; Tateishi A; Imamura T; Miki H; Abe S; Cho S; Matsushita T; Goto T
Anticancer Res; 1998; 18(4B):2859-64. PubMed ID: 9713475
[TBL] [Abstract][Full Text] [Related]
5. Hyperthermic isolated regional perfusion of the limb with carboplatin.
Daryanani D; de Vries EG; Guchelaar HJ; van Weerden TW; Hoekstra HJ
Eur J Surg Oncol; 2000 Dec; 26(8):792-7. PubMed ID: 11087648
[TBL] [Abstract][Full Text] [Related]
6. Continuous hyperthermic peritoneal perfusion with cisplatin for the treatment of peritoneal mesothelioma.
Ma GY; Bartlett DL; Reed E; Figg WD; Lush RM; Lee KB; Libutti SK; Alexander HR
Cancer J Sci Am; 1997; 3(3):174-9. PubMed ID: 9161783
[TBL] [Abstract][Full Text] [Related]
7. Preoperative cisplatin for initial treatment of limb osteosarcoma: its local effect and impact on prognosis.
Abe S; Nishimoto Y; Isu K; Ishii T; Goto T;
Cancer Chemother Pharmacol; 2002 Oct; 50(4):320-4. PubMed ID: 12357307
[TBL] [Abstract][Full Text] [Related]
8. Hyperthermic isolated perfusion with tumor necrosis factor-alpha and doxorubicin for the treatment of limb-threatening soft tissue sarcoma: the experience of the Italian Society of Integrated Locoregional Treatment in Oncology (SITILO).
Di Filippo F; Giacomini P; Rossi CR; Santinami M; Garinei R; Anzà M; Deraco M; Botti C; Perri P; Cavaliere F; Di Angelo P; Sofra C; Sperduti I; Pasqualoni R; Di Filippo S; Corrias F; Armenti A; Ferraresi V
In Vivo; 2009; 23(2):363-7. PubMed ID: 19414428
[TBL] [Abstract][Full Text] [Related]
9. Preoperative isolated limb infusion of Doxorubicin and external irradiation for limb-threatening soft tissue sarcomas.
Hegazy MA; Kotb SZ; Sakr H; El Dosoky E; Amer T; Hegazi RA; Farouk O
Ann Surg Oncol; 2007 Feb; 14(2):568-76. PubMed ID: 17094027
[TBL] [Abstract][Full Text] [Related]
10. Doxorubicin in isolation limb perfusion in the treatment of advanced limb soft tissue sarcoma.
Di Filippo F; Garinei R; Anzà M; Cavaliere F; Giannarelli D; Cagol PP; Rossi CR; Santinami M; Deraco M; Botti C; Perri P; Di Filippo S; Piarulli L; Bruno P
J Exp Clin Cancer Res; 2003 Dec; 22(4 Suppl):81-7. PubMed ID: 16767912
[TBL] [Abstract][Full Text] [Related]
11. Hyperthermic isolated regional perfusion for the treatment of osteosarcoma in the lower extremity.
Nakano H; Tateishi A; Miki H; Imamura T; Cho S; Abe S; Matsushita T
Am J Surg; 1999 Jul; 178(1):27-32. PubMed ID: 10456698
[TBL] [Abstract][Full Text] [Related]
12. Hyperthermic isolated perfusion with low-dose tumor necrosis factor alpha and doxorubicin for the treatment of limb-threatening soft tissue sarcomas.
Rossi CR; Mocellin S; Pilati P; Foletto M; Campana L; Quintieri L; De Salvo GL; Lise M
Ann Surg Oncol; 2005 May; 12(5):398-405. PubMed ID: 15915374
[TBL] [Abstract][Full Text] [Related]
13. [Isolation perfusion chemotherapy using cisplatin in malignant tumors of the extremities].
Takeyama S; Tateishi A; Miki H; Yamanashi M; Hayashi I; Higaki S; Kozima T; Iizima T
Gan To Kagaku Ryoho; 1989 Apr; 16(4 Pt 2-3):1764-70. PubMed ID: 2543321
[TBL] [Abstract][Full Text] [Related]
14. Liposomal doxorubicin with and without TNFalpha in the perfusional treatment of advanced soft tissue limb sarcoma: preliminary results.
Di Filippo F; Anzà M; Garinei R; Cavaliere F; Perri P; Botti C; Di Angelo P; Di Filippo S; Maini CL; Pasqualoni R; Di Segni S; Colantonio S; Bruno P; Piarulli L; Principi F
In Vivo; 2006; 20(6A):735-8. PubMed ID: 17203757
[TBL] [Abstract][Full Text] [Related]
15. Experimental and clinical evaluation of cisplatin-containing microspheres as intraperitoneal chemotherapy for ovarian cancer.
Sugiyama T; Kumagai S; Nishida T; Ushijima K; Matsuo T; Yakushiji M; Hyon SH; Ikada Y
Anticancer Res; 1998; 18(4B):2837-42. PubMed ID: 9713471
[TBL] [Abstract][Full Text] [Related]
16. Factors predictive of acute regional toxicity after isolated limb infusion with melphalan and actinomycin D in melanoma patients.
Kroon HM; Moncrieff M; Kam PC; Thompson JF
Ann Surg Oncol; 2009 May; 16(5):1184-92. PubMed ID: 19224289
[TBL] [Abstract][Full Text] [Related]
17. Platinum agents in the treatment of osteosarcoma: efficacy of cisplatin vs. carboplatin in human osteosarcoma cell lines.
Robson H; Meyer S; Shalet SM; Anderson E; Roberts S; Eden OB
Med Pediatr Oncol; 2002 Dec; 39(6):573-80. PubMed ID: 12376980
[TBL] [Abstract][Full Text] [Related]
18. Isolated lung perfusion with cisplatin in a rat lung solitary tumor nodule model.
Li TS; Sugi K; Ueda K; Nawata K; Nawata S; Esato K
Anticancer Res; 1998; 18(6A):4171-6. PubMed ID: 9891463
[TBL] [Abstract][Full Text] [Related]
19. [Limb salvage in osteosarcoma. Significance of preoperative isolation perfusion chemotherapy].
Takeyama S; Tateishi A; Higaki S
Gan To Kagaku Ryoho; 1987 May; 14(5 Pt 2):1399-404. PubMed ID: 3473976
[TBL] [Abstract][Full Text] [Related]
20. Phase II study of cisplatin in advanced osteogenic sarcoma. European Organization for Research on Treatment of Cancer Soft Tissue and Bone Sarcoma Group.
Gasparini M; Rouesse J; van Oosterom A; Wagener T; Somers R; Russel JA; Voûte PA; Bramwell V; Thomas D; Sylvester R
Cancer Treat Rep; 1985 Feb; 69(2):211-3. PubMed ID: 3855699
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]